Published in Med J Armed Forces India on July 21, 2011
Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care (2003) 2.90
Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care (1998) 2.09
Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. A comparison of treatments. Diabetes Care (1996) 1.08
Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American population. Diabetes Care (2000) 1.07
Diabetic foot ulcers: current concepts. J Foot Ankle Surg (1999) 1.05
Long-term results following operation for diabetic foot problems: arterial disease confers a poor prognosis. Eur J Vasc Endovasc Surg (2000) 0.93
Who is at risk for diabetic foot ulceration? Clin Podiatr Med Surg (1998) 0.89
Evaluation and treatment of the infected foot in a community teaching hospital. J Am Podiatr Med Assoc (1996) 0.84
[Critical analysis of vascular explorations in diabetic complications]. J Mal Vasc (2001) 0.83
Decreasing amputation rates in patients with diabetes mellitus. An outcome study. J Am Podiatr Med Assoc (2002) 0.82
Amputations in diabetic patients: a plea for footsparing surgery. Acta Chir Belg (2001) 0.82
Team approach toward lower extremity amputation prevention in diabetes. J Am Podiatr Med Assoc (1997) 0.81
Perioperative and rehabilitative outcomes after amputation for ischaemic leg gangrene. Ann Acad Med Singapore (2000) 0.81
[The diabetic foot seen by the surgeon. Personal experience]. Minerva Chir (2000) 0.79
Factors associated with pedal ulceration in patients with diabetes mellitus. J Am Podiatr Med Assoc (1997) 0.79
Vascular evaluation of the problem diabetic foot. Clin Podiatr Med Surg (1998) 0.78